Skip to content

To compare ROX index and HACOR scale for predicting success of high flow nasal cannula in patients with low oxygen respiratory failure.

Comparison of ROX index with HACOR scale in predicting success of high-flow nasal cannula in acute hypoxemic respiratory failure. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/10/074936
Enrollment
70
Registered
2024-10-08
Start date
Unknown
Completion date
Unknown
Last updated
2024-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J80- Acute respiratory distress syndrome Health Condition 2: J471- Bronchiectasis with (acute) exacerbation Health Condition 3: J09-J18- Influenza and pneumonia Health Condition 4: J60-J70- Lung diseases due to external agents Health Condition 5: J454- Moderate persistent asthma Health Condition 6: J90-J94- Other diseases of the pleura Health Condition 7: J80-J84- Other respiratory diseases principally affecting the interstitium Health Condition 8: J18- Pneumonia, unspecified

Interventions

Intervention1: Application of high flow nasal cannula in patients with hypoxemic respiratory failure.: Patient with hypoxemic respiratory failure arriving at department(RICU) will be assessed at 0 hrs
respiratory rate 40/min or Spo2 90 despite max FiO2, worsening hypercapnia, deterioration of GCS 12, severe hemodynamic instability. After HFNC application, Respiratory rate oxygenation index(ROX) AN

Sponsors

VMMC and SAFDARJUNG HOSPITAL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient presenting with acute hypoxemic respiratory failure (room air spo2 equal to less than 90% or PaO2 less than 60 mmhg). The need for oxygen supplemental via face mask greater than 9 L/min to maintain spo2 greater than 92%.

Exclusion criteria

Exclusion criteria: Requiring immediate mechanical ventilation Cardiopulmonary arrest Pneumothorax Severe respiratory acidosis or suspected hypercapnic respiratory failure. Hemodynamic instability with MAP less than 65mmhg.

Design outcomes

Primary

MeasureTime frame
Primary outcome was defined as no intolerance requiring hfnc removal and no escalation to invasive or non invasive ventilation within 48 hours after hfnc application i.e HFNC will be terminated if any of the following criteria for termination is met adopted from British thoracic guidelines; respiratory rate 40/min or Spo2 90 despite max FiO2, worsening hypercapnia, deterioration of GCS 12, severe hemodynamic instability.Timepoint: After applying HFNC, respiratory rate oxygenation (ROX) and HACOR(The HACOR score is based on five components: heart rate, acidosis, consciousness, oxygenation, and respiratory rate) score will be calculated at 1,2 and 6 hours after first application of HFNC. Patient will be observed for 48 hours to see if there is escalation of oxygenation support in the form of ventilator(invasive or non invasive)

Secondary

MeasureTime frame
To compare individual components of the scoring indexTimepoint: Individual components of scoring (heart rate, respiratory rate & SpO2) will be assessed at 1,2 & 6 hours after application of HFNC.

Countries

India

Contacts

Public ContactTejawat Kushal Kumar

Vardhaman mahavir medical College and Safdarjung hospital

drgupta.nk@gmail.com9350859929

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026